Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

Update Il y a 4 ans
Reference: NCT01328379

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to investigate the safety and efficacy of a lower dose of dalfampridine extended release tablets compared to the currently approved dose in improving walking in Multiple Sclerosis (MS) patients.


Inclusion criteria

  • Multiple sclerosis

Links